Novartis Earnings Date, Estimates, & History

$83.57
+0.77 (+0.93 %)
(As of 09/23/2021 04:00 PM ET)
Add
Compare
Today's Range
$83.53
$83.98
50-Day Range
$82.80
$95.14
52-Week Range
$77.04
$98.52
Volume1.85 million shs
Average Volume1.89 million shs
Market Capitalization$186.92 billion
P/E Ratio21.16
Dividend Yield2.51%
Beta0.54

Earnings Summary

Upcoming
Earnings Date
Oct. 26
Estimated

Actual EPS
(Jul. 20)
$1.66
Beat By $0.14

Consensus EPS
(Jul. 20)
$1.52

Last Year's Q3 EPS
(7/21/2020)
$1.36

Novartis Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Novartis Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Novartis (NYSE:NVS) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20211$1.52$1.52$1.52 
Q2 20211$1.57$1.57$1.57 
Q3 20211$1.61$1.61$1.61 
Q4 20211$1.54$1.54$1.54 
FY 20214$6.24$6.24$6.24

NVS Earnings Information

Novartis last announced its earnings data on July 20th, 2021. The reported $1.66 earnings per share for the quarter, topping analysts' consensus estimates of $1.52 by $0.14. The firm had revenue of $12.96 billion for the quarter, compared to the consensus estimate of $12.41 billion. Its quarterly revenue was up 14.2% compared to the same quarter last year. Novartis has generated $5.75 earnings per share over the last year ($3.95 diluted earnings per share) and currently has a price-to-earnings ratio of 21.2. Earnings for Novartis are expected to grow by 6.53% in the coming year, from $6.28 to $6.69 per share. Novartis has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, October 26th, 2021 based off prior year's report dates.

Novartis (NYSE:NVS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
10/26/2021
(Estimated)
        
7/20/20216/30/2021$1.52$1.66+$0.14$2.00$12.41 billion$12.96 billion    
4/26/20213/31/2021$1.54$1.52($0.02)$2.13$12.63 billion$12.41 billion  
1/25/202112/31/2020$1.37$1.34($0.03)$1.76$12.86 billion$12.77 billion  
11/1/20209/30/2020$1.45$1.52+$0.07$2.20$12.58 billion$12.26 billion  
7/21/20206/30/2020$1.31$1.36+$0.05$1.89$11.77 billion$11.35 billion  
4/28/20203/31/2020$1.37$1.56+$0.19$2.15$11.92 billion$12.28 billion  
1/29/2020Q4 2019$1.32$1.31($0.01)$2.13$12.49 billion$12.40 billion
10/22/20199/30/2019$1.31$1.41+$0.10$1.93$11.67 billion$12.17 billion  
7/18/20196/30/2019$1.20$1.34+$0.14($0.27)$11.45 billion$11.76 billion  
4/24/20193/31/2019$1.11$1.21+$0.10$1.64$11.76 billion$11.11 billion  
1/30/201912/31/2018$1.33$1.24($0.09)$1.97$13.33 billion$13.27 billion
10/18/20189/30/2018$1.31$1.32+$0.01$1.93$12.88 billion$12.78 billion  
7/18/20186/30/2018$1.27$1.29+$0.02($0.79)$12.93 billion$13.16 billion
4/19/2018Q1$1.25$1.28+$0.03$1.70$12.45 billion$12.69 billion
1/24/2018n/a$1.16$1.20+$0.04$1.56$12.65 billion$12.92 billion  
10/24/20179/30/2017$1.25$1.29+$0.04$1.70$12.21 billion$12.41 billion
7/18/2017Q2 17$1.16$1.22+$0.06$1.59$12.20 billion$12.24 billion
4/25/20173/31/2017$1.10$1.13+$0.03$1.56$11.59 billion$11.54 billion
1/25/2017Q416$1.12$1.12$1.84$12.44 billion$12.32 billion
10/25/2016Q316$1.19$1.23+$0.04$1.65$12.24 billion$12.13 billion  
7/19/2016Q216$1.18$1.23+$0.05$1.69$12.33 billion$12.47 billion  
4/21/2016Q116$1.18$1.17($0.01)$1.50$11.90 billion$11.60 billion  
1/27/2016Q415$1.18$1.14($0.04)$1.78$12.64 billion$12.52 billion  
10/27/2015Q315$1.31$1.27($0.04)$1.77$12.66 billion$12.30 billion  
7/21/2015Q215$1.20$1.27+$0.07$1.77$12.45 billion$12.70 billion  
4/23/2015Q115$1.12$1.33+$0.21($2.66)$12.90 million$11.94 billion
1/27/2015Q314$1.13$1.21+$0.08$1.81$14.68 billion$14.63 billion
10/28/2014Q3 2014$1.29$1.28($0.01)$1.25$14.14 billion$14.70 billion
7/17/2014Q214$1.36$1.36$1.69$14.83 billion$14.64 billion  
4/24/2014Q1 2014$1.33$1.31($0.02)$1.43$14.25 billion$14.02 billion  
1/29/2014Q4 2013$1.22$1.20($0.02)$1.58$15.16 billion$15.08 billion
10/22/2013Q3 2013$1.31$1.25($0.06)$1.60$14.28 billion$14.34 billion
7/17/2013Q2 2013$1.30$1.30$1.57$14.39 billion$14.50 billion  
4/24/2013Q1 2013$1.25$1.30+$0.05$1.63$14.02 million$14.02 billion  
1/23/2013Q412$1.19$1.27+$0.08$14.42 billion$14.80 billion
10/25/2012$1.34$1.34
7/19/2012$1.33$1.38+$0.05
4/24/2012$1.30$1.27($0.03)
1/25/2012$1.26$1.23($0.03)
10/25/2011$1.45$1.45
7/19/2011$1.46$1.48+$0.02
4/19/2011$1.30$1.41+$0.11
1/27/2011$1.25$1.14($0.11)  
10/21/2010Q3 2010$1.20$1.36+$0.16$1.73
7/15/2010Q2 2010$1.13$1.20+$0.07$1.34
1/26/2010Q4 2009$1.16$1.01($0.15)$1.01
10/22/2009Q3 2009$0.95$0.92($0.03)$0.92
4/23/2009Q1 2009$0.87$0.87$0.87
1/28/2009Q4 2008$0.79$0.66($0.13)$0.66
10/20/2008Q3 2008$0.99$0.92($0.07)$0.92
7/17/2008Q2 2008$0.93$0.99+$0.06$0.99
1/23/2008Q4 2007$0.67$0.41($0.26)$0.41
(Earnings results data provided by Zacks Investment Research)
speech bubbles
speech bubbles











Novartis (NYSE:NVS) Earnings Frequently Asked Questions

When is Novartis's earnings date?

Novartis has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, October 26th, 2021 based off last year's report dates. Learn more on NVS's earnings history

Did Novartis beat their earnings estimates last quarter?

In the previous quarter, Novartis (NYSE:NVS) reported $1.66 earnings per share (EPS) to beat the analysts' consensus estimate of $1.52 by $0.14. Learn more on NVS's earnings details

How can I listen to Novartis's earnings conference call?

The conference call for Novartis's latest earnings report can be listened to online. Listen to Conference Call

How can I read Novartis's conference call transcript?

The conference call transcript for Novartis's latest earnings report can be read online. Read Transcript

How much revenue does Novartis generate each year?

Novartis (NYSE:NVS) has a recorded annual revenue of $48.66 billion.

How much profit does Novartis generate each year?

Novartis (NYSE:NVS) has a recorded net income of $8.07 billion. NVS has generated $5.75 earnings per share over the last four quarters.

What is Novartis's price-to-earnings ratio?

Novartis (NYSE:NVS) has a trailing price-to-earnings ratio of 21.16 and a forward price-to-earnings ratio of 13.31. The price/earnings-to-growth ratio is 2.07.

What is Novartis's EPS forecast for next year?

Novartis's earnings are expected to grow from $6.28 per share to $6.69 per share in the next year, which is a 6.53% increase.

This page was last updated on 9/24/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.